EQUINOX NEPREMICNINE d.d. Revenue

In the year 2024, EQUINOX NEPREMICNINE d.d. had annual revenue of 8.67M EUR with 11.36% growth. EQUINOX NEPREMICNINE d.d. had revenue of 2.45M in the quarter ending December 31, 2024, with 7.72% growth.

Revenue

8.67M

Revenue Growth

+11.36%

P/S Ratio

12.05

Revenue / Employee

n/a

Employees

n/a

Market Cap

104.52M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.67M	884.25K	11.36%
Dec 31, 2023	7.79M	442.80K	6.03%
Dec 31, 2022	7.34M	629.52K	9.38%
Dec 31, 2021	6.71M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition